share_log

Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Mar 18 18:19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more